利血平与乳腺癌的关系。 - Suppr

Suppr

超能文献

Reserpine use in relation to breast cancer.

作者信息

Heinonen O P, Shapiro S, Tuominen L, Turunen M I

出版信息

Lancet. 1974 Sep 21;2(7882):675-7. doi: 10.1016/s0140-6736(74)93259-0.

DOI:10.1016/s0140-6736(74)93259-0

PMID:4142957

Abstract

摘要

相似文献

Reserpine use in relation to breast cancer.

Lancet. 1974 Sep 21;2(7882):675-7. doi: 10.1016/s0140-6736(74)93259-0.

Reserpine and breast cancer.

Lancet. 1974 Sep 21;2(7882):669-71.

Letter: Rauwolfia derivatives and breast cancer.

Lancet. 1974 Oct 19;2(7886):966-7.

Letter: Rauwolfia derivatives and breast cancer.

Lancet. 1974 Nov 30;2(7892):1315-7.

Reserpine and breast cancer in women in germany.

Eur J Clin Pharmacol. 1977 Jan 3;11(2):79-83. doi: 10.1007/BF00562896.

Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women.

Lancet. 1974 Sep 21;2(7882):672-5. doi: 10.1016/s0140-6736(74)93258-9.

[Reserpine and breast cancer].

Lakartidningen. 1974 Nov 13;71(46):4607-8.

Reserpine and breast cancer.

Lancet. 1976 Dec 11;2(7998):1296. doi: 10.1016/s0140-6736(76)92050-x.

Rauwolfia derivatives and breast cancer.

Lancet. 1977 Jan 15;1(8003):140-1. doi: 10.1016/s0140-6736(77)91726-3.

Matched-pairs study of reserpine use and breast cancer.

Lancet. 1975 Aug 16;2(7929):296-300. doi: 10.1016/s0140-6736(75)92731-2.

引用本文的文献

Structural characterization of monoterpene indole alkaloids in ethanolic extracts of species by liquid chromatography with quadrupole time-of-flight mass spectrometry.

J Pharm Anal. 2016 Dec;6(6):363-373. doi: 10.1016/j.jpha.2016.04.008. Epub 2016 May 7.

Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies.

Oncotarget. 2017 Jul 10;8(37):62545-62560. doi: 10.18632/oncotarget.19117. eCollection 2017 Sep 22.

The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.

PLoS One. 2016 Aug 10;11(8):e0159672. doi: 10.1371/journal.pone.0159672. eCollection 2016.

Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?

Curr Hypertens Rep. 2012 Jun;14(3):183-92. doi: 10.1007/s11906-012-0263-x.

Critical review of cancer risk associated with angiotensin receptor blocker therapy.

Vasc Health Risk Manag. 2011;7:741-7. doi: 10.2147/VHRM.S13552. Epub 2011 Dec 12.

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies.

Eur J Epidemiol. 2010 Apr;25(4):245-51. doi: 10.1007/s10654-010-9451-7. Epub 2010 Apr 1.

Prolactin and breast cancer etiology: an epidemiologic perspective.

J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):41-53. doi: 10.1007/s10911-008-9063-y. Epub 2008 Feb 2.

The role of prolactin in mammary carcinoma.

Endocr Rev. 2003 Feb;24(1):1-27. doi: 10.1210/er.2001-0036.

Carcinogenicity of antihypertensive therapy.

Curr Hypertens Rep. 2002 Jun;4(3):195-201. doi: 10.1007/s11906-002-0007-4.

Antihypertensive therapy and cancer risk.

Drug Saf. 2001;24(10):727-39. doi: 10.2165/00002018-200124100-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Reserpine use in relation to breast cancer.

Lancet. 1974 Sep 21;2(7882):675-7. doi: 10.1016/s0140-6736(74)93259-0.

Reserpine and breast cancer.

Lancet. 1974 Sep 21;2(7882):669-71.

Letter: Rauwolfia derivatives and breast cancer.

Lancet. 1974 Oct 19;2(7886):966-7.

Letter: Rauwolfia derivatives and breast cancer.

Lancet. 1974 Nov 30;2(7892):1315-7.

Reserpine and breast cancer in women in germany.

Eur J Clin Pharmacol. 1977 Jan 3;11(2):79-83. doi: 10.1007/BF00562896.

Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women.

Lancet. 1974 Sep 21;2(7882):672-5. doi: 10.1016/s0140-6736(74)93258-9.

[Reserpine and breast cancer].

Lakartidningen. 1974 Nov 13;71(46):4607-8.

Reserpine and breast cancer.

Lancet. 1976 Dec 11;2(7998):1296. doi: 10.1016/s0140-6736(76)92050-x.

Rauwolfia derivatives and breast cancer.

Lancet. 1977 Jan 15;1(8003):140-1. doi: 10.1016/s0140-6736(77)91726-3.

Matched-pairs study of reserpine use and breast cancer.

Lancet. 1975 Aug 16;2(7929):296-300. doi: 10.1016/s0140-6736(75)92731-2.

引用本文的文献

Structural characterization of monoterpene indole alkaloids in ethanolic extracts of species by liquid chromatography with quadrupole time-of-flight mass spectrometry.

J Pharm Anal. 2016 Dec;6(6):363-373. doi: 10.1016/j.jpha.2016.04.008. Epub 2016 May 7.

Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies.

Oncotarget. 2017 Jul 10;8(37):62545-62560. doi: 10.18632/oncotarget.19117. eCollection 2017 Sep 22.

The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.

PLoS One. 2016 Aug 10;11(8):e0159672. doi: 10.1371/journal.pone.0159672. eCollection 2016.

Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?

Curr Hypertens Rep. 2012 Jun;14(3):183-92. doi: 10.1007/s11906-012-0263-x.

Critical review of cancer risk associated with angiotensin receptor blocker therapy.

Vasc Health Risk Manag. 2011;7:741-7. doi: 10.2147/VHRM.S13552. Epub 2011 Dec 12.

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies.

Eur J Epidemiol. 2010 Apr;25(4):245-51. doi: 10.1007/s10654-010-9451-7. Epub 2010 Apr 1.

Prolactin and breast cancer etiology: an epidemiologic perspective.

J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):41-53. doi: 10.1007/s10911-008-9063-y. Epub 2008 Feb 2.

The role of prolactin in mammary carcinoma.

Endocr Rev. 2003 Feb;24(1):1-27. doi: 10.1210/er.2001-0036.

Carcinogenicity of antihypertensive therapy.

Curr Hypertens Rep. 2002 Jun;4(3):195-201. doi: 10.1007/s11906-002-0007-4.

Antihypertensive therapy and cancer risk.

Drug Saf. 2001;24(10):727-39. doi: 10.2165/00002018-200124100-00002.